INS and Hyperglycemia: Reduced maternal hyperglycaemia during pregnancy may decrease fetal insulin secretion, preventing adverse adaptations such as cardiomyocyte hypertrophy, vascular stiffness, and altered cardiac remodelling.62 Reduced maternal sugar intake may also modulate oxidative stress and inflammation, key factors in fetal vascular development.